Literature DB >> 8437215

Immunological responses of mice and cattle to baculovirus-expressed F and H proteins of rinderpest virus: lack of protection in the presence of neutralizing antibody.

M Bassiri1, S Ahmad, L Giavedoni, L Jones, J T Saliki, C Mebus, T Yilma.   

Abstract

Rinderpest is a highly contagious viral disease of ruminants and has greater than 95% morbidity and mortality. The etiological agent, rinderpest virus (RPV), is a member of the family Paramyxoviridae and the genus Morbillivirus. Immune responses to both the hemagglutinin (H) and the fusion (F) antigens of morbilliviruses play an important role in the prevention of infection, and only attenuated live vaccines have been shown to provide protective immunity against the group. The lack of protection with inactivated vaccines has been attributed to the denaturation of the F glycoprotein of the virus. Our previous study, however, demonstrated complete protection of cattle vaccinated with infectious vaccinia virus recombinants expressing the H (vRVH) or F (vRVF) protein alone, even in the presence of only 4 U of serum-neutralizing (SN) antibody to RPV (T. Yilma, D. Hsu, L. Jones, S. Owens, M. Grubman, C. Mebus, M. Yamanaka, and B. Dale, Science 242:1058-1061, 1988). We have constructed recombinant baculoviruses that express the F (Fb) and H (Hb) glycoproteins of RPV. Furthermore, we have analyzed the immune responses of mice and cattle to these antigens. Cattle vaccinated with Fb or Hb or a mixture of both antigens were not protected from challenge inoculation with RPV, even when the SN titer was greater than in cattle vaccinated with vRVF alone. This lack of protection, in the presence of SN antibody, would indicate that live attenuated and recombinant vaccines induce immune responses necessary for protection (e.g., cell-mediated immunity) that are not generated by subunit or inactivated whole-virus vaccines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437215      PMCID: PMC237491     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease.

Authors:  R R Redfield; D C Wright; W D James; T S Jones; C Brown; D S Burke
Journal:  N Engl J Med       Date:  1987-03-12       Impact factor: 91.245

3.  Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

Authors:  T M Varsanyi; B Morein; A Löve; E Norrby
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  An enzyme-linked immunosorbent assay for the detection of IgG, IgA and IgM antibodies to rinderpest virus in experimentally infected cattle.

Authors:  J Anderson; L W Rowe; W P Taylor; J R Crowther
Journal:  Res Vet Sci       Date:  1982-03       Impact factor: 2.534

5.  Analysis of the polypeptides synthesized in rinderpest virus-infected cells.

Authors:  M J Grubman; C Mebus; B Dale; M Yamanaka; T Yilma
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

6.  Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.

Authors:  E Norrby; G Enders-Ruckle; V Meulen
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

7.  Sequence analysis and editing of the phosphoprotein (P) gene of rinderpest virus.

Authors:  M Yamanaka; B Dale; T Crisp; B Cordell; M Grubman; T Yilma
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

8.  Cloning and sequence analysis of the hemagglutinin gene of the virulent strain of rinderpest virus.

Authors:  M Yamanaka; D Hsu; T Crisp; B Dale; M Grubman; T Yilma
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

9.  Cloning of the fusion gene of rinderpest virus: comparative sequence analysis with other morbilliviruses.

Authors:  D Hsu; M Yamanaka; J Miller; B Dale; M Grubman; T Yilma
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

10.  Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.

Authors:  R Drillien; D Spehner; A Kirn; P Giraudon; R Buckland; F Wild; J P Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

View more
  12 in total

1.  Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins.

Authors:  Paulo H Verardi; Fatema H Aziz; Shabbir Ahmad; Leslie A Jones; Berhanu Beyene; Rosemary N Ngotho; Henry M Wamwayi; Mebratu G Yesus; Berhe G Egziabher; Tilahun D Yilma
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors.

Authors:  H Tatsuo; N Ono; Y Yanagi
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.

Authors:  Rebecca Herbert; Jana Baron; Carrie Batten; Michael Baron; Geraldine Taylor
Journal:  Vet Res       Date:  2014-02-26       Impact factor: 3.683

4.  Effect of immunization with plasmid DNA encoding for rinderpest virus matrix protein on systemic rinderpest virus infection in rabbits.

Authors:  B Pahar; B Sharma; A C Goel
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

5.  MVA recombinants expressing the fusion and hemagglutinin genes of PPRV protects goats against virulent challenge.

Authors:  Dev Chandran; Kolli Bhaktavatsala Reddy; Shahana Pallichera Vijayan; Parthasarthy Sugumar; Gudavalli Sudha Rani; Ponsekaran Santha Kumar; Lingala Rajendra; Villuppanoor Alwar Srinivasan
Journal:  Indian J Microbiol       Date:  2010-03-16       Impact factor: 2.461

6.  Assessment of the control measures of category A diseases of the Animal Health Law: Infection with rinderpest virus (Rinderpest).

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Simon Gubbins; Genevieve Libeau; Andrea Gervelmeyer; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-01-25

Review 7.  Peste des petits ruminants virus infection of small ruminants: a comprehensive review.

Authors:  Naveen Kumar; Sunil Maherchandani; Sudhir Kumar Kashyap; Shoor Vir Singh; Shalini Sharma; Kundan Kumar Chaubey; Hinh Ly
Journal:  Viruses       Date:  2014-06-06       Impact factor: 5.048

8.  Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.

Authors:  José Manuel Rojas; Miguel Avia; Elena Pascual; Noemí Sevilla; Verónica Martín
Journal:  Vet Res       Date:  2017-11-21       Impact factor: 3.683

9.  Oral immunization of cattle with hemagglutinin protein of rinderpest virus expressed in transgenic peanut induces specific immune responses.

Authors:  Abha Khandelwal; G Lakshmi Sita; M S Shaila
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

10.  Depletion of CD8+ T cells from vaccinated goats does not affect protection from challenge with wild-type peste des petits ruminants virus.

Authors:  Michael D Baron; Sophia Hodgson; Katy Moffat; Mehnaz Qureshi; Simon P Graham; Karin E Darpel
Journal:  Transbound Emerg Dis       Date:  2020-12-20       Impact factor: 4.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.